✦ LIBER ✦

JIKEI HEART Study—A Morbi-Mortality and Remodeling Study with Valsartan in Japanese Patients with Hypertension and Cardiovascular Disease

✍ Scribed by Seibu Mochizuki; Mitsuyuki Shimizu; Ikuo Taniguchi; Kiyoshi Kanae; Satoru Yoshida; Naoko Tajima; Bjorn Dahlöf

Book ID: 111575929
Publisher: Springer US
Year: 2004
Tongue: English
Weight: 127 KB
Volume: 18
Category: Article
ISSN: 0920-3206
DOI: 10.1023/b:card.0000041250.00079.84

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Valsartan in a Japanese population with

Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study

✍ Seibu Mochizuki; Björn Dahlöf; Mitsuyuki Shimizu; Katsunori Ikewaki; Makoto Yosh 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 198 KB

Retraction—Valsartan in a Japanese popul

Retraction—Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study

✍ The Lancet Editors, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 37 KB

Cardiovascular morbidity and mortality i

Cardiovascular morbidity and mortality in hypertensive patients with atrial fibrillation: The LIFE study

✍ Wachtell, Kristian; Hornestam, Björn; Lehto, Mika; Slotweiner, David J.; Gerdts, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 200 KB

Effect of valsartan on morbidity and mor

Effect of valsartan on morbidity and mortality in heart failure patients with a history of hypertension: results from the valsartan heart failure trial

✍ Holwerda, N.J.; Opie, Lionel; Feliciano, Nancy; Bodner, Janet 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Genetic Risk Score Associations With Car

Genetic Risk Score Associations With Cardiovascular Disease and Mortality in the Diabetes Heart Study

✍ Cox, A. J.; Hsu, F.-C.; Ng, M. C. Y.; Langefeld, C. D.; Freedman, B. I.; Carr, J 📂 Article 📅 2014 🏛 American Diabetes Association 🌐 English ⚖ 683 KB

## OBJECTIVE Given the high rates of cardiovascular disease (CVD) and associated mortality in individuals with type 2 diabetes, identifying and understanding predictors of CVD events and mortality could help inform clinical management in this high-risk group. Recent large-scale genetic studies may

Rationale and design of the NAGOYA HEART

Rationale and design of the NAGOYA HEART Study: Comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance

✍ Kunihiro Matsushita; Takashi Muramatsu; Takahisa Kondo; Kengo Maeda; Satoshi Shi 📂 Article 📅 2010 🏛 Elsevier 🌐 Japanese ⚖ 367 KB